Mark Bregman

Managing General Partner, Quidnet Ventures | Seed-Stage Deep Tech VC | Backing New Zealand’s Science & Engineering Founders | Active Investor Plus (AIP) Approved Fund

📍 Mill Valley, California, United States🔄 Updated September 2026💼 7 investments📅 22 years investing🗓 Last invested Sep 2022𝕏 @upgrade_to_unlock
VC🌍 United States
7
Total investments
0
Early stage
4
Mid stage
0
Late stage
22y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Sep 2022
Ambit is the platform for customer service at scale through automated conversations. Top brands, including The Warehouse Group, Noel Leeming, Hallenstein Brothers, Vector, Vodafone, Tower Insurance and more, have used Ambits enterprise solution to drive revenue, control costs to serve, improve agent efficiency, and increase customer satisfaction. Learn more at https://www.ambit.ai - Ambit’s Conversational Platform: https://www.ambit.ai/platform - Blog: https://www.ambit.ai/resources - Case Studies: https://www.ambit.ai/customers
Board Member
Aug 2021
Litmaps is a Literature Discovery Tool that helps researchers find vital scientific papers they didnt know about and tell a better research story. Visualize, expand, and communicate your research expertise. A Litmap is a picture that shows the relationship between a collection of scientific papers based on their citations, popularity and currency. Science is the answer to many of humanity’s challenges. As a species, we must do anything and everything we can to accelerate the process of scientific discovery. Litmaps has a role to play connecting the dots between scientists and discoveries in order to help advance humanity.
Board Member
Aug 2021
Arcanum is a NZ-based AI company accelerating back-office teams wanting to 10x their productivity. We have a team of AI Assistants to support your growth: Archie: Finance Arcos: Support Desk Arcel: Human Resource Archana: Sustainability Talk to us about recruiting a new AI team member today!
Board Member
Jul 2021
MaramaLabs’ CloudSpec instrument has a valuable capability for UV-Vis analysis – it can measure through cloudy liquids. If you think of all the liquids you encounter daily you will begin to appreciate how much of a stumbling block this is for UV-Vis. CloudSpec’s novel ability – scatter-corrected absorption (SCA) spectroscopy – enables quantitative analysis of the constituents of cloudy liquids quickly and easily. CloudSpec is a perfect fit for nanomedicine development, manufacturing and quality control. Nanomedicines are too small to see but they protect and deliver new classes of drugs – vaccines, oncological treatments, gene therapies and more – safely and effectively into the body. With CloudSpec, drug developers can quantify potency in seconds, accurately and easily, for substantial time and cost savings.
Board Member
2006
ShoreTel is now part of Mitel. Together, we look forward to powering connections in the cloud that are brilliantly simple. A global market leader in business communications powering more than two billion business connections, Mitel (Nasdaq:MITL) (TSX:MNW) helps businesses and service providers connect, collaborate and provide innovative services to their customers. Our innovation and communications experts serve more than 60 million business users in more than 100 countries.
Experience · 11 entries
All (11)
Investments (7)
Board (7)
2022
Board Member
Sep 2022
Ambit is the platform for customer service at scale through automated conversations. Top brands, including The Warehouse Group, Noel Leeming, Hallenstein Brothers, Vector, Vodafone, Tower Insurance and more, have used Ambits enterprise solution to drive revenue, control costs to serve, improve agent efficiency, and increase customer satisfaction. Learn more at https://www.ambit.ai - Ambit’s Conversational Platform: https://www.ambit.ai/platform - Blog: https://www.ambit.ai/resources - Case Studies: https://www.ambit.ai/customers
2021
Board Member
Aug 2021
Litmaps is a Literature Discovery Tool that helps researchers find vital scientific papers they didnt know about and tell a better research story. Visualize, expand, and communicate your research expertise. A Litmap is a picture that shows the relationship between a collection of scientific papers based on their citations, popularity and currency. Science is the answer to many of humanity’s challenges. As a species, we must do anything and everything we can to accelerate the process of scientific discovery. Litmaps has a role to play connecting the dots between scientists and discoveries in order to help advance humanity.
Board Member
Aug 2021
Arcanum is a NZ-based AI company accelerating back-office teams wanting to 10x their productivity. We have a team of AI Assistants to support your growth: Archie: Finance Arcos: Support Desk Arcel: Human Resource Archana: Sustainability Talk to us about recruiting a new AI team member today!
Board Member
Jul 2021
MaramaLabs’ CloudSpec instrument has a valuable capability for UV-Vis analysis – it can measure through cloudy liquids. If you think of all the liquids you encounter daily you will begin to appreciate how much of a stumbling block this is for UV-Vis. CloudSpec’s novel ability – scatter-corrected absorption (SCA) spectroscopy – enables quantitative analysis of the constituents of cloudy liquids quickly and easily. CloudSpec is a perfect fit for nanomedicine development, manufacturing and quality control. Nanomedicines are too small to see but they protect and deliver new classes of drugs – vaccines, oncological treatments, gene therapies and more – safely and effectively into the body. With CloudSpec, drug developers can quantify potency in seconds, accurately and easily, for substantial time and cost savings.
2020
General Partner, Quidnet Ventures
Jul 2020
Investing in scalable, capital efficient New Zealand businesses created by exceptional founding teams with global vision from inception. We provide New Zealand companies with access to the distribution channels, advisors, and talent pools needed to accelerate growth in the USA.
Show all 11 entries ↓
Investment activity
2004–2022 · 7 investments
2004120061200812021320221
Recent (last 2 years)Earlier